Sino Medical Sciences Technology Inc. (SHA:688108)
China flag China · Delayed Price · Currency is CNY
22.27
+0.06 (0.27%)
At close: Feb 13, 2026

SHA:688108 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
357.7291.67188.64203.42287.76544.83
Cash & Short-Term Investments
357.7291.67188.64203.42287.76544.83
Cash Growth
59.02%54.62%-7.27%-29.31%-47.18%-15.73%
Accounts Receivable
13.637.478.9420.281266.67
Other Receivables
7.1811.420.490.530.860.7
Receivables
20.8118.99.4320.8212.8667.38
Inventory
102.7789.51118.2298.1384.8864.75
Prepaid Expenses
-00.012.6--
Other Current Assets
2.73.3127.8829.9445.346.48
Total Current Assets
483.97403.39344.18354.9430.8723.43
Property, Plant & Equipment
117.45135.79165.95176.77172.58139.16
Long-Term Investments
--1418.9533.655
Goodwill
46.2246.22---2.58
Other Intangible Assets
179.9189.3153.452.8773.9282.07
Long-Term Deferred Tax Assets
95.2111.88105.3391.7844.175.86
Long-Term Deferred Charges
415.73413.88375.91369.2333.07253.06
Other Long-Term Assets
0.340.08127.053.1414.896.34
Total Assets
1,3391,3011,1861,0681,1031,217
Accounts Payable
39.1713.9420.1213.418.5720.07
Accrued Expenses
24.0170.6457.6562.1955.1863.38
Short-Term Debt
91.4753.0553.5535.545.01-
Current Portion of Long-Term Debt
15.84.560.76---
Current Portion of Leases
-11.5114.9610.9511.78-
Current Income Taxes Payable
5.090.02---0.13
Current Unearned Revenue
1.071.871.120.790.410.79
Other Current Liabilities
45.9936.433.129.311.67.8
Total Current Liabilities
222.61192.02151.27132.1892.5692.18
Long-Term Debt
123.25137105.3---
Long-Term Leases
17.5218.9924.9211.8327.49-
Long-Term Unearned Revenue
6.6113.322121.942.48
Long-Term Deferred Tax Liabilities
3740.8920.2222.7221.4717.53
Other Long-Term Liabilities
--1.4611.414.4727.44
Total Liabilities
407402.22324.17180.13157.92139.63
Common Stock
416.05413.46410410410410
Additional Paid-In Capital
661.9651.98608.92596.87527.37545.23
Retained Earnings
-178.32-199.44-200.94-161.31-8.44122.33
Comprehensive Income & Other
1.120.891.971.52-1.090.31
Total Common Equity
900.75866.89819.96847.08927.841,078
Minority Interest
31.0631.4541.6940.417.33-
Shareholders' Equity
931.81898.34861.65887.48945.161,078
Total Liabilities & Equity
1,3391,3011,1861,0681,1031,217
Total Debt
248.05225.11199.4958.3144.27-
Net Cash (Debt)
109.6566.56-10.85145.11243.48544.83
Net Cash Growth
----40.40%-55.31%-15.73%
Net Cash Per Share
0.260.18-0.030.360.601.33
Filing Date Shares Outstanding
416.05413.46410410410410
Total Common Shares Outstanding
416.05413.46410410410410
Working Capital
261.36211.37192.9222.72338.24631.26
Book Value Per Share
2.172.102.002.072.262.63
Tangible Book Value
674.64631.36766.55794.21853.92993.22
Tangible Book Value Per Share
1.621.531.871.942.082.42
Machinery
-265.54286278.74226.45179.29
Construction In Progress
-1.171.556.6611.9240.94
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.